HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
It is believed that the inherent tolerogenic property of the liver is involved in the chronicity of hepatitis B virus (HBV) infection [ 1 ]. However, exposure to HBV in adults usually leads to spontaneous clearance of the virus and the induction of potent and effective anti-HBV T cell immunity in the liver [ 2 ], suggesting that the immune microenvironment of the liver switches from limiting to allowing effector T cell responses during acute resolution of HBV infection. To date, it remains largely unknown how the immune microenvironment of the liver is regulated and by which mechanism a favorable intrahepatic anti-HBV T cell response is generated in an infected individual. Liver sinusoidal endothelial cells (LSECs) play key roles in intrahepatic immune surveillance against infection by regulating the activation of local immune cells [ 3 ]. We have previously demonstrated that LSECs switch from a tolerogenic to an immunogenic state and trigger cytotoxic effector CD8 T cell activation under inflammatory conditions [ 4 , 5 ]. Here, we investigated whether LSECs exhibit plasticity and switch from a tolerogenic to an immunogenic state upon HBV exposure. We first analyzed LSEC-mediated T cell suppression during the course of acute resolution of HBV replication using the HBV hydrodynamic injection (HDI) mouse model. LSECs were freshly purified at 14 days post injection (dpi) and cocultured with T cell receptor (TCR)-activated T cells (Fig. 1A ). These T cells produced significantly higher levels of IFNγ than those cocultured with control LSECs (Fig. 1A ). LSECs from HBV HDI mice also showed less suppression of CD8 T cell proliferation than LSECs from control mice (Fig. 1A ). These results suggest that the ability of LSECs to suppress T cell activation was abolished in HBV HDI mice at 14 dpi. Next, we examined whether exposure to specific HBV antigens altered the ability of LSECs to suppress T cell activation. Our data showed that in vitro pretreatment of LSECs with recombinant HBeAg (rHBeAg) completely abolished the suppression of T cell IFNγ production in a dose-dependent manner (Fig. 1B ). Activated T cells cocultured with LSECs exposed to HBeAg in vivo also showed significantly increased IFNγ production compared with those cocultured with control LSECs (Fig. 1B ). Moreover, CD3/CD28 Dynabead-activated human PBMCs cocultured with rHBeAg-pretreated human LSECs produced significantly higher amounts of IFNγ than PBMCs cultured with control LSECs (Fig. 1B ). These data suggest that HBeAg stimulation could abrogate LSEC-mediated T cell suppression in both mice and humans. Fig. 1: HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance. A LSECs from mice that were hydrodynamically injected with pSM2 plasmid (HBV) or PBS (HDI Ctrl) were isolated 14 days postinjection (dpi) and cocultured with polyclonally stimulated splenocytes at a ratio of 1:2 (LSECs: splenocytes). Anti-CD3/anti-CD28–stimulated splenocytes were used as a responder control (RC). Unstimulated splenocytes were used as a negative control (NC). IFNγ production was measured after 48 h. CFSE-labeled polyclonally stimulated splenocytes were cocultured with LSECs, and after 72 h, CD8 T cell proliferation was analyzed by flow cytometry. B Naïve mouse or primary human LSECs were treated with recombinant HBeAg (rHBeAg) or left untreated (Ctrl) for 24 h, washed and cocultured with polyclonally stimulated splenocytes or PBMCs at a ratio of 1:2. LSECs from mice that were hydrodynamically injected with pcDNA3.1/HBeAg or the pcDNA3.1/null plasmid at 2 dpi were isolated and cocultured with polyclonally stimulated splenocytes at a ratio of 1:2. IFNγ production was measured after 48 h. Anti-CD3/anti-CD28–stimulated splenocytes were used as a responder control (RC). Unstimulated splenocytes were used as a negative control (NC). C LSECs from naïve mice were mock-treated or treated with rHBeAg, and total RNA was extracted from the cells 6 h later for RNA-seq analysis. Log2-fold changes in the top 20 differentially expressed genes (DEGs), KEGG pathway enrichment analysis and gene set enrichment analysis (GSEA), as determined by RNA-seq analysis. D Supernatants of rHBeAg-LSECs or HBV-LSECs were analyzed for TNF α and IL-27. E Polyclonally stimulated splenocytes were cocultured with rHBeAg-LSECs or HBV-LSECs, and then 10 μg/ml anti–IL-27 Abs (aIL-27) or anti–TNFα Abs (aTNFα) were added to the cocultures, with untreated cocultures as the control (Ctrl). IFNγ production was measured by ELISA after 48 h. F Polyclonally stimulated splenocytes were cocultured with LSECs from naïve mice, and 50 ng/ml rIL-27 or 100 ng/ml rTNFα was added to the cocultures. IFNγ production was measured by ELISA after 48 h. Anti-CD3/anti-CD28-stimulated splenocytes only were used as a responder controls (RC). Unstimulated splenocytes were used as a negative control (NC). Unpaired t -test or one-way ANOVA is used. Error bars, mean ± SEM; *
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, HBV exposure leads to a switch from a tolerogenic state to an immunogenic state in LSECs.”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [320]
In the citing paper
“This process involves the release of LSEC-derived cytokines, such as IL-27, which promote the activation of T cells [320].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [320]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepatitis B Virus Infection — Natural History and Clinical Consequences
Ganem, D., & Prince, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031087 · Cited by 2,357
Antigen-presenting cell function in the tolerogenic liver environment
Thomson, A. W., & Knolle, P. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2858 · Cited by 805
Liu, J., Jiang, M., Ma, Z., Dietze, K. K., Zelinskyy, G., Yang, D., Dittmer, U., Schlaak, J. F., Roggendorf, M., & Lu, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301262 · Cited by 70
Self-citationThe role of liver sinusoidal cells in local hepatic immune surveillance
Wohlleber, D., & Knolle, P. A. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.74 · Cited by 64
Huang, S., Zou, S., Chen, M., Gao, X., Chen, L., Yang, X., Yu, Q., Zhao, X., Du, Y., Yang, X., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700921 · Cited by 31
Self-citation
Cited by
The evolving role of liver sinusoidal endothelial cells in liver health and disease
McConnell, M. J., Kostallari, E., Ibrahim, S. H., & Iwakiri, Y. (2023) · Hepatology · doi:10.1097/hep.0000000000000207 · Cited by 189
“In this respect, based on studies that have been conducted in mice, rats and human livers, aging LSECs display augmented p16 expression (indicating senescence), enhanced mitochondrial oxidative stress and increased expression of inflammatory genes, such as tumor necrosis factor alpha (TNF α ), Interleukin (IL)-1, and…”
Influential(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
“This process involves the release of LSEC-derived cytokines, such as IL-27, which promote the activation of T cells [320].”
Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC
Khan, M. N., Mao, B., Hu, J., Shi, M., Wang, S., Rehman, A. U., & Li, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1472430 · Cited by 52
Recent advances in understanding T cell activation and exhaustion during HBV infection
Wang, L., Zeng, X., Wang, Z., Fang, L., & Liu, J. (2023) · Virologica Sinica · doi:10.1016/j.virs.2023.10.007 · Cited by 38
“…been widely regarded as a key immunomodulator for promoting host innate and adaptive immune tolerance during chronic HBV infection via a number of different mechanisms, such as down-regulation of TLR expression, modulating macrophage function and inducing MDSC activation, etc (Xie et al., 2021).”
BackgroundInfluentialSelf-citationMurine CXCR3+CXCR6+γδT Cells Reside in the Liver and Provide Protection Against HBV Infection
Wang, Y., Guan, Y., Hu, Y., Li, Y., Lü, N., & Zhang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.757379 · Cited by 19
“Liver Sinusoidal Endothelium Cells Mediate Retention of Liver-Resident CXCR3CXCR6 gdT Cells LSECs secrete a variety of chemokines that promote the recruitment of immune cells (38, 39).”
Background
Metadata
- Authors
- Xie, X., Luo, J., Broering, R., Zhu, D., Zhou, W., Lu, M., Zheng, X., Dittmer, U., Yang, D., & Liu, J.
- Affiliations
- Wuhan Union Hospital (CN)
- Essen University Hospital (DE)
- Corresponding author
- Liu, Jia
- ORCID
- Venue
- Cellular & Molecular Immunology
- Published
- 2021-09-15
- Volume
- 18
- Issue
- 11
- Pages
- 2572-2574
- ISSN
- 1672-7681 (ISSN-L)
- 2042-0226
- PMC
- PMC8546047
- OpenAlex
- W3200080649
- Cited by
- 11
- References
- 5
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 3
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cellular and Molecular Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81861138044, 91742114, 2017ZX10202203, 91642118)
- Tongji University
- Topics
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Keywords
- hepatitis B virus, HBeAg, liver sinusoidal endothelial cells, CD8+ T cell immunity, HBV clearance, T cell tolerance, T cell suppression, interferon-gamma, liver immune microenvironment, chronic hepatitis B, T cell activation, endothelial plasticity
- MeSH terms
- Cell Plasticity, Animals, Cytotoxicity, Immunologic, Disease Models, Animal, Hepatitis B e Antigens, Hepatitis B virus, Humans, Immune Tolerance, Liver, CD8-Positive T-Lymphocytes, Hepatitis B, Chronic, Endothelial Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance. https://app.cochat.ai/papers/10.1038/s41423-021-00769-7
- The paper
- Xie, X., Luo, J., Broering, R., Zhu, D., Zhou, W., Lu, M., Zheng, X., Dittmer, U., Yang, D., & Liu, J. (2021). HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance. Cellular & Molecular Immunology. https://doi.org/10.1038/s41423-021-00769-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.